Assertio Surpasses Medical Peers with 54.4% YTD Gain

Assertio (ASRT) has outperformed its Medical peers this year, with a 54.4% return, compared to an average of -6.5% for the sector. The stock has a Zacks Rank of #2 (Buy) and its full-year earnings estimate has increased 110% over the past 90 days. Other Medical stocks that have outperformed the sector include BrightSpring Health Services, Inc. (BTSG), which is up 12.4% year-to-date.